Hederagenin is a Highly Selective Antagonist of the Neuropeptide FF Receptor 1 that Reveals Mechanisms for Subtype Selectivity
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Hederagenin is a Highly Selective Antagonist of the Neuropeptide FF Receptor 1 that Reveals Mechanisms for Subtype Selectivity ; day:09 ; month:12 ; year:2024 ; extent:12
Angewandte Chemie ; (09.12.2024) (gesamt 12)
- Urheber
-
Lentschat, Hannah
Liessmann, Fabian
Tydings, Claiborne
Schermeng, Tina
Stichel, Jan Dirk
Urban, Nicole
Schaefer, Michael
Meiler, Jens
Beck‐Sickinger, Annette G.
- DOI
-
10.1002/ange.202417786
- URN
-
urn:nbn:de:101:1-2412101319159.240912007805
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:36 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Lentschat, Hannah
- Liessmann, Fabian
- Tydings, Claiborne
- Schermeng, Tina
- Stichel, Jan Dirk
- Urban, Nicole
- Schaefer, Michael
- Meiler, Jens
- Beck‐Sickinger, Annette G.
Ähnliche Objekte (12)
Hederagenin is a Highly Selective Antagonist of the Neuropeptide FF Receptor 1 that Reveals Mechanisms for Subtype Selectivity
Structural basis of antagonist selectivity in endothelin receptors
GABAA receptor subtype selectivity of the proconvulsant rodenticide TETS
Finally an oral V2 selective vasopressin antagonist
Understanding subtype-selective allosteric modulation of GABAAreceptors
Modulating dopamine receptors subtype selectivity by thiophene and benzothiophene based derivates
Modulating dopamine receptors subtype selectivity by thiophene and benzothiophene based derivatives
Binding kinetics drive G protein subtype selectivity at the β1-adrenergic receptor
Discovery and molecular basis of subtype-selective cyclophilin inhibitors
Structure‐Based Evolution of Subtype‐Selective Neurotensin Receptor Ligands
Binding, Thermodynamics, and Selectivity of a Non-peptide Antagonist to the Melanocortin-4 Receptor
Cell-based monitoring and multiplexing of ERBB receptor activity, antagonist selectivity and pathway responses
Hederagenin is a Highly Selective Antagonist of the Neuropeptide FF Receptor 1 that Reveals Mechanisms for Subtype Selectivity
Structural basis of antagonist selectivity in endothelin receptors
GABAA receptor subtype selectivity of the proconvulsant rodenticide TETS
Finally an oral V2 selective vasopressin antagonist
Understanding subtype-selective allosteric modulation of GABAAreceptors
Modulating dopamine receptors subtype selectivity by thiophene and benzothiophene based derivates
Modulating dopamine receptors subtype selectivity by thiophene and benzothiophene based derivatives
Binding kinetics drive G protein subtype selectivity at the β1-adrenergic receptor
Discovery and molecular basis of subtype-selective cyclophilin inhibitors
Structure‐Based Evolution of Subtype‐Selective Neurotensin Receptor Ligands
Binding, Thermodynamics, and Selectivity of a Non-peptide Antagonist to the Melanocortin-4 Receptor
Cell-based monitoring and multiplexing of ERBB receptor activity, antagonist selectivity and pathway responses
Hederagenin is a Highly Selective Antagonist of the Neuropeptide FF Receptor 1 that Reveals Mechanisms for Subtype Selectivity
Structural basis of antagonist selectivity in endothelin receptors
GABAA receptor subtype selectivity of the proconvulsant rodenticide TETS
Finally an oral V2 selective vasopressin antagonist
Understanding subtype-selective allosteric modulation of GABAAreceptors
Modulating dopamine receptors subtype selectivity by thiophene and benzothiophene based derivates
Modulating dopamine receptors subtype selectivity by thiophene and benzothiophene based derivatives
Binding kinetics drive G protein subtype selectivity at the β1-adrenergic receptor
Discovery and molecular basis of subtype-selective cyclophilin inhibitors
Structure‐Based Evolution of Subtype‐Selective Neurotensin Receptor Ligands
Binding, Thermodynamics, and Selectivity of a Non-peptide Antagonist to the Melanocortin-4 Receptor